Total Count 67

JAMJOOM PHARMA - Analyst Estimates

14/01/2026
SNB Capital sets Q4 2025 earnings estimates
Argaam Special
13/01/2026
GIB Capital previews Q4 2025 earnings 
Argaam
07/01/2026
United Securities issues Q4 2025 earnings forecasts
ِArgaam special
19/11/2025
How did analysts view Jamjoom Pharma Q3 2025 financials?
Argaam Special
03/11/2025
United Securities says Jamjoom Pharma Q3 2025 net profit below estimates, keeps rating
Argaam
25/10/2025
AlJazira Capital sets Jamjoom Pharma’s TP, rating after Q3 2025 results
Argaam
22/10/2025
Analysts outline forecasts ahead of Jamjoom Pharma’s Q3 202 results
Argaam Special
13/10/2025
Ubhar Capital posts Q3 earnings forecasts for Saudi firms
Argaam Special
09/10/2025
GIB Capital issues Q3 2025 earnings forecasts for firms under coverage
Argaam Special
07/10/2025
SNB Capital sets Q3 2025 earnings estimates
Argaam Special
05/10/2025
United Securities issues Q3 2025 earnings forecasts
Argaam Special
02/10/2025
AlJazira Capital issues Q3 2025 profit forecasts
Argaam Special
25/08/2025
How did analysts view Jamjoom Pharma Q2 2025 financials?
Argaam Special
18/08/2025
United Securities comments on Jamjoom Pharma’s financials, maintains rating
Argaam
06/08/2025
Jamjoom Pharma Q2 2025 results in line with estimates: GIB Capital
Argaam
27/07/2025
Jamjoom Pharma posts in-line Q2 2025 results, rating unchanged: AlJazira Capital
Argaam
07/07/2025
GIB Capital issues Q2 2025 earnings forecasts for Saudi companies
Argaam
06/07/2025
Q2 2025 earnings preview: AlJazira Capital
Argaam Special
06/07/2025
United Securities issues Q2 2025 earnings forecast
Argaam
03/07/2025
Al Rajhi Capital issues earnings estimates for Q2 2025
Argaam
14/05/2025
How did analysts view Jamjoom Pharma Q1 2025 financials?
Argaam Special
05/05/2025
Ubhar Capital: Jamjoom Pharma Q1 profit above estimates, TP unchanged
Argaam
29/04/2025
AlJazira Capital initiates coverage on Saudi pharmaceuticals sector, sets ratings
Argaam
14/04/2025
Al Rajhi Capital issues Q1 2025 profit forecasts for TASI-listed firms
Argaam
14/04/2025
GIB Capital issues Q1 2025 earnings estimates
Argaam
10/04/2025
SNB Capital sets Q1 2025 earnings estimates
Argaam
06/04/2025
United Securities issues Q1 2025 earnings forecast
Argaam Special
08/03/2025
Al Rajhi Capital sets Jamjoom Pharma rating, TP
Argaam
30/01/2025
Jamjoom Pharma Q4 2024: What are analysts predicting?
Argaam Special
25/01/2025
Ubhar Capital initiates coverage of Jamjoom Pharma, sets rating, TP
Argaam
12/01/2025
SNB Capital sets Q4 2024 earnings estimates
Argaam Special
12/01/2025
Osool & Bakheet previews Q4 2024 earnings estimates
Argaam Special
09/01/2025
United Securities issues Q4 2024 earnings forecasts
Argaam
06/01/2025
GIB Capital issues Q4 2024 earnings estimates
Argaam
02/01/2025
Al Rajhi Capital issues Q4 2024 profit forecasts for TASI-listed firms
Argaam Special
01/01/2025
SNB Capital forecasts Tadawul earnings to rise 8% in 2025
Argaam
23/12/2024
Analyst ratings, average TP for Jamjoom Pharma post-Q3 2024
Argaam Special
24/10/2024
What do analysts expect from Jamjoom Pharma's Q3 2024 results?
Argaam Special
10/10/2024
GIB Capital's forecast on Q3 2024 earnings
Argaam Special
08/10/2024
Osool & Bakheet previews Q3 2024 earnings estimates
Argaam Special
07/10/2024
Al Rajhi Capital issues Q3 2024 earnings forecasts for more Tadawul-listed firms
Argaam
06/10/2024
United Securities: As earnings loom, what to expect in Q3 2024?
Argaam
15/09/2024
SNB Capital initiates coverage on Jamjoom Pharma, sets TP
Argaam
11/09/2024
How analysts rated Jamjoom Pharma after Q2 results?
Argaam Special
09/09/2024
Saudi pharmaceuticals sector seen to grow: Al Rajhi Capital
ِArgaam
12/08/2024
United Securities says Jamjoom Pharma’s net profit beats expectations
Argaam
05/08/2024
Analyst forecasts on Jamjoom Pharma Q2 2024 profit
Argaam Special
16/07/2024
United Securities issues Q2 earnings estimates
Argaam
09/07/2024
Osool & Bakheet issues Q2 2024 earnings forecast
Argaam
07/07/2024
GIB Capital previews Q2 2024 earnings
Argaam

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2026, Argaam Investment, All Rights Reserved
Call Request